According to updated data of the Southeastern Minnesota cohort (with a long-term follow-up) adverse risk factors for progression of MGUS to active MM include an M-protein ≥ 15 g/L and an abnormal SFLC ratio in patients with non-IgM MGUS. This evidence concerns the gene MYOM2 and Miyoshi myopathy.